Health Care/Hospital
Huakang Biomedical Signs MOU with a World Leading Fertility Group Endeavors to Develop PRC Assisted Reproductive Treatment (ART) Market
HONG KONG, Oct. 30, 2019 /PRNewswire/ -- Huakang Biomedical Holdings Company Limited ("Huakang Biomedical", the "Group", HKSE：08622) is pleased to announce that Huakang Biomedical Company Limited ("Huakang HK"), a direct wholly-owned subsidiary of the Group, entered into a Memorandum of Understan...
2019-10-30 19:00
6096
EC Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Assay
SAN DIEGO, Oct. 30, 2019 /PRNewswire/ -- Invivoscribe, Inc. announced today that the European Commission (EC) has approved the Astellas drug XOSPATA™ (gilteritinib) as a monotherapy for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) withFLT3 mutations (FL...
2019-10-30 18:00
1891
AI Medical Technology Enters "One Belt, One Road" Initiative; Ping An Good Doctor Attends 3rd Future Investment Initiative
SHANGHAI, Oct. 30, 2019 /PRNewswire/ -- The third edition of Future Investment Initiative (FII) began inSaudi Arabia's capital Riyadh on 29 October. The world's leading online healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; stock code: 0183...
2019-10-30 13:57
4684
Atrial Fibrillation Projected to Affect 72 Million People in Asia Pacific by 2050 According to New Report from Biosense Webster
* The prevalence of atrial fibrillation (AF) in Asia Pacific is increasing, currently impacting more than 16 million people in this region.[1] * Current projections show that the number of cases of AF in Asia Pacific will rise to 72 million inAsia Pacific – more than twice as many AF patients ...
2019-10-30 10:00
2910
World Pancreatic Cancer Day Campaign Launches to Raise Awareness of the Risks and Symptoms of the World's Toughest Cancer
More than 80 organizations from 30 countries to advocate for early diagnosis of pancreatic cancer onThursday, Nov. 21 MANHATTAN BEACH, California, Oct. 30, 2019 /PRNewswire/ -- Pancreatic cancer has the lowest survival rate among all major cancers because few people know the risks and symptoms a...
2019-10-30 05:47
858
NeoDynamics Receives Regulatory Approval for new Breast Cancer Biopsy System
STOCKHOLM, Oct. 30, 2019 /PRNewswire/ -- NeoDynamics today received confirmation from Intertek (Notified Body) that the improved version of the new system for breast cancer biopsy, NeoNavia, is accepted as an update to the already EU approved study version. The upgraded pulse biopsy system includ...
2019-10-30 00:13
1455
Global MEMS and Sensors Fab Capacity to Grow 25 Percent Through 2023, SEMI Reports
MILPITAS, California, Oct. 29, 2019 /PRNewswire/ -- Total worldwide installed capacity for MEMS and sensors fabs is forecast to grow 25 percent to 4.7 million wafers* per month from 2018 to 2023, driven by explosive demand across communications, transportation, medical, mobile, industrial and oth...
2019-10-29 22:00
2059
Effect of Climate Change on the Brain, Link to Alzheimer's and Parkinson's, to be Key Focus of Discussion at XXIV World Congress of Neurology
DUBAI, United Arab Emirates, Oct. 29, 2019 /PRNewswire/ -- World Federation of Neurology -- Breakthrough studies indicate that the impact of air pollution and rising incidents of stroke, Parkinson's and other neurological diseases are potentially linked. The environmental impact of climate change...
2019-10-29 21:53
1228
WAT Medical will be returning to 2019 MEDICA to exhibit their innovative wearable technologies
VANCOUVER, British Columbia, Oct. 29, 2019 /PRNewswire/ -- From November 18-21, 2019, WAT Medical will be showcasing their EmeTerm, the anti-vomiting wristband, and HeadaTerm, the anti-migraine head patch, at one of the largest healthcare trade shows, MEDICA, inDusseldorf, Germany at Stand Hall 1...
2019-10-29 21:00
1656
Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video
AUSTIN, Texas, Oct. 29, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the confirmation of a further$500,000 non-dilutive funding in the form of a loan from the Texas A&M SOFINEX funding agency of the Walloon Region to support the development of its sub...
2019-10-29 20:30
6317
CEM Corporation acquires key assets of Intavis Bioanalytical Instruments
MATTHEWS, North Carolina, Oct. 29, 2019 /PRNewswire/ -- CEM Corporation today announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, with headquarters inCologne, Germany. The acquisition allows CEM to strengthen its...
2019-10-29 20:30
2433
New Study in Hong Kong Shows Home Ambulatory Chemotherapy Improves Cancer Patient's Quality of Life
HONG KONG, Oct. 29, 2019 /PRNewswire/ -- Quality of life is an important aspect of a cancer patient's treatment journey. Hong Kong Society of Clinical Oncology today announced the findings from a recent research study inHong Kong, which shows that home ambulatory chemotherapy can improve cancer p...
2019-10-29 16:52
3303
Herbalife Nutrition Foundation Opens Six New Casa Herbalife Programs in Asia Pacific, Supporting Nutrition Programs for Children in Need
HONG KONG, Oct. 29, 2019 /PRNewswire/ -- Continuing its mission to improve communities around the world, the Herbalife Nutrition Foundation (HNF) has announced the addition of 29 new Casa Herbalife Nutrition programs in 20 countries around the globe. Of the 29 new programs, six are based in theA...
2019-10-29 15:00
2151
Herbalife Nutrition Foundation Opens Six New Casa Herbalife Programs in Asia Pacific, Supporting Nutrition Programs for Children in Need
HONG KONG, Oct. 29, 2019 /PRNewswire/ -- Continuing its mission to improve communities around the world, the Herbalife Nutrition Foundation (HNF) has announced the addition of 29 new Casa Herbalife Nutrition programs in 20 countries around the globe. Of the 29 new programs, six are based in theA...
2019-10-29 15:00
2023
Amaris B. Clinic Reveals Health Benefits of VASER Liposuction
SINGAPORE, Oct. 29, 2019 /PRNewswire/ -- According to a compelling clinical study titled "Strategies For Reducing Body Fat Mass: Effects Of Liposuction And Exercise On Cardiovascular Risk Factors And Adiposity. Diabetes, Metabolic Syndrome And Obesity: Targets And Therapy"[1] by Benatti et al....
2019-10-29 14:43
1644
Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit
GERMANTOWN, Maryland, Oct. 29, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (fka Neuralstem, Inc) (NASDAQ: CUR) a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, will present at the 7th China Renaissance Healthcare and Life Sciences Leaders...
2019-10-29 13:17
3274
European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma
Not intended for US, Canada and UK-based media -- EU approval based on JAVELIN Renal 101 trial results demonstrating significant improvement in progression-free survival with BAVENCIO in combination with axitinib compared with sunitinib -- Combination regimen approved across all IMDC prognosti...
2019-10-29 02:00
1796
Neurodegenerative Disorder Therapeutics Market Sees a Silver Lining with Cell and Gene Therapies
The market is expected to reach $15.44 billion by 2024 at a CAGR of 8.30% with improvements in early disease diagnosis, finds Frost & Sullivan SANTA CLARA, California, Oct. 28, 2019 /PRNewswire/ -- With both large pharmaceutical companies and mid-sized biotechs adopting emerging technologies suc...
2019-10-28 23:13
1178
Werum IT Solutions honored with Frost & Sullivan Customer Value Leadership Award
LONDON, Oct. 28, 2019 /PRNewswire/ -- Based on its recent analysis of the global manufacturing execution system (MES) market for pharmaceuticals, biotechnology, and cell & gene therapies, Frost & Sullivan recognizes Werum IT Solutions with the 2019 Global MES for Pharmaceuticals, Biotechnology, a...
2019-10-28 22:00
1011
Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis
- ADVISE clinical trial initiated and enrollment progressing - Evaluating patients with the clinical diagnosis of moderate-to-severe atopic dermatitis - Significant unmet need for an oral therapy in atopic dermatitis SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ...
2019-10-28 20:30
3165
Week's Top Stories
Most Reposted
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
[Picked up by 350 media titles]
2024-09-18 11:30
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
[Picked up by 315 media titles]
2024-09-16 11:50
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
[Picked up by 284 media titles]
2024-09-14 17:37
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
[Picked up by 283 media titles]
2024-09-19 14:00
Watsons-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively
[Picked up by 274 media titles]
2024-09-19 08:00
Most Read
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
2024-09-14 17:37
10233
Maiji Mountain Grottoes: Carved in stone, evolving in time
2024-09-14 13:23
8644
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
2024-09-16 11:50
8579
Vision China: US, China urged to find right path in ties
2024-09-14 01:10
8149
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
2024-09-18 11:30
7800